Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 39, Issue 5, 2010, Pages 368-375

  Kim, Yong Hun ^a   Kim, Soung Min ^a   Kim, Yu Kyoung ^a   Hong, Sam Pyo ^a   Kim, Myung Jin ^a   Myoung, Hoon ^a  

^a Seoul National University   (South Korea)

Author keywords

Oral squamous cell carcinoma; Prognostic marker; Survivin

Indexed keywords

CD31 ANTIGEN; SURVIVIN; APOPTOSIS REGULATORY PROTEIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LYMPH NODE METASTASIS; MALE; NONHUMAN; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; EVALUATION STUDY; HAMSTER; KAPLAN MEIER METHOD; MESOCRICETUS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ADULT; AGED; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; CRICETINAE; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MESOCRICETUS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77951260186     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00844.x     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Schliephake H. Prognostic relevance of molecular markers of oral cancer - a review. Int J Oral Maxillofac Surg 2003 32 : 233 245. (Pubitemid 36700729)
3. Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001 40 : 1117 1123. (Pubitemid 32108606)
4. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999 341 : 452 453. (Pubitemid 29362524)
5. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998 58 : 5071 5074. (Pubitemid 28521163)
6. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 2000 31 : 1080 1085. (Pubitemid 30233232)
7. Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma role of neurotrophic signals and genetic abnormalities. Hum Cell 1998 11 : 115 124.
8. Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: reexpression of survivin messenger RNA as a prognosis marker in nonsmall-cell lung cancers. J Clin Oncol 1999 17 : 2100 2104. (Pubitemid 29318841)
9. Xing N, Qian J, Bostwick D, Bergstralh E, Young CY. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein surviving. Prostate 2001 48 : 7 15. (Pubitemid 32545072)
10. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin a promising tumor biomarker. Cancer Lett 2007 28 : 249.
11. Ouhtit A, Matrougui K, Bengrine A, Koochekpour S, Zerfaoui M, Yousief Z. Survivin is not only a death encounter but also a survival protein for invading tumor cells. Front Biosci 2007 1 : 12.
12. Kim MJ, Lim KY, Kim JW, Nam IW, Lee JH, Myoung H. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Lett 2005 28 : 224.
13. Hsue SS, Chen YK, Lin LM. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation. Oral Oncol 2008 44 : 43 9.
14. Bosari S. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992 23 : 755 761.
15. Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD. Prognostic importance of survivin in breast cancer. Br J Cancer 2003 88 : 1077 1083. (Pubitemid 36560779)
16. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997 3 : 917 921. (Pubitemid 27353455)
17. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A. Expression of survivin and Bcl-2 in the normal human endometrium. Mol. Hum. Repord 2000 6 : 529 534. (Pubitemid 30365798)
18. Suzuki A, Hayashida M, Ito T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 2000 19 : 3225 3234. (Pubitemid 30487409)
19. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold D, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998 152 : 43 9.
20. Glinsky GV, Glinsky VV. Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett 1996 101 : 43 51.
21. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 1997 115 : 185 193.
22. Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001 95 : 92 5.
23. Yoshida H, Ishiko O, Sumi T, Matsumoto Y, Ogita S. Survivin bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 2001 19 : 537 542.
24. Uren AG, Wong L, Pakusch M, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000 10 : 1319 1328.
25. Sierra A, Castellsague X, Escobedo A, Lloveras B, Ramnrez MG, Moreno A. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer. Int J Cancer 2000 89 : 142 147. (Pubitemid 30185922)